Home › Degenerative Nerve Diseases › Oregon
Degenerative Nerve Diseases clinical trials in Oregon
3 studies for Degenerative Nerve Diseases are looking for participants at sites in Oregon.
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Summit Headlands, Portland
- Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Tigard
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Oregon Health &Science University, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.